International Moon Day 2025: Why we celebrate it, its history and significance
Historically, the Moon has played a vital role in shaping ancient calendars, inspiring poets, and symbolizing the unknown—until that changed on July 20, 1969. On that day, Neil Armstrong and Buzz Aldrin took humanity's first steps on the lunar surface during the Apollo 11 mission, turning the dream of reaching the Moon into reality.
Explore courses from Top Institutes in
Select a Course Category
Public Policy
Cybersecurity
Degree
Design Thinking
Finance
Data Analytics
healthcare
others
Others
Digital Marketing
PGDM
Healthcare
Management
Technology
Leadership
MBA
CXO
Data Science
Data Science
Artificial Intelligence
Product Management
Project Management
Operations Management
MCA
Skills you'll gain:
Duration:
12 Months
IIM Calcutta
Executive Programme in Public Policy and Management
Starts on
undefined
Get Details
Skills you'll gain:
Economics for Public Policy Making
Quantitative Techniques
Public & Project Finance
Law, Health & Urban Development Policy
Duration:
12 Months
IIM Kozhikode
Professional Certificate Programme in Public Policy Management
Starts on
Mar 3, 2024
Get Details
To commemorate this groundbreaking achievement, International Moon Day is celebrated each year on July 20, marking the anniversary of the first human landing on the Moon. Armstrong's unforgettable words—'That's one small step for man, one giant leap for mankind'—still echo today as a testament to the boundless potential of human exploration.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
How Much Does It Cost to Rent a Private Jet - The Prices May Surprise You!
Private Jet I Search Ads
Learn More
Undo
In 2021, the United Nations officially recognized International Moon Day through Resolution 76/76, aiming not only to honour past accomplishments but to ignite global enthusiasm for future lunar science, exploration, and peaceful cooperation in outer space.
Theme for 2025: 'One Moon, One Vision, One Future'
This year, the UN Office for Outer Space Affairs (UNOOSA) has announced the theme 'One Moon, One Vision, One Future', emphasizing the need for international unity in
lunar exploration
. The theme reflects a shared vision where the Moon—and outer space as a whole—is seen as a common heritage of humanity. According to UNOOSA, it aims to promote 'international collaboration and shared goals for lunar exploration.'
Live Events
Why Moon Day 2025 Is Especially Significant
International Moon Day 2025
arrives at a pivotal moment in space exploration. Several spacefaring nations are actively pursuing lunar missions, such as:
NASA's Artemis program
India's Chandrayaan-3
China's Chang'e series
These missions signal a renewed global interest in exploring and understanding the Moon—not just for science, but for the future possibility of human settlement and resource utilization.
This year's observance shines a spotlight on:
The Moon's scientific, cultural, and historical relevance
Milestones in space exploration, from Luna 2 (1959) to Artemis and beyond
Prospects for lunar energy harvesting, research outposts, and long-term human presence
The importance of peaceful cooperation in space, in line with the 1967 Outer Space Treaty
The Committee on the Peaceful Uses of Outer Space (COPUOS) supports Moon Day initiatives that aim to inspire the next generation of scientists, engineers, and astronauts.
Celebrations Around the World
International Moon Day is celebrated with a wide range of global events, including:
Public stargazing and telescope viewings
Lectures by astronomers and space experts
Educational workshops for students
Community discussions on space policy and innovation
These events bring together people of all ages to celebrate humanity's relationship with the Moon and foster excitement about future possibilities.
The main global event for 2025 will be held in Dubai, UAE, at the University of Dubai. This international gathering will unite scientists, educators, students, and space professionals in honour of one of humanity's most remarkable achievements—and our shared aspirations for what lies ahead.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
43 minutes ago
- Time of India
So it was not diabetes but the common diabetes pill which was causing heart disease! Shocking research reveals the unbelievable!
For many living with type 2 diabetes, managing blood sugar is a daily reality. Often, medications come as a lifeline, and among them, sulfonylureas like glipizide are popular choices, especially in the US. They've been around for decades, are affordable, and have shown effective results in keeping glucose in check. But now, a new study has cast a shadow over this commonly used medicine. Researchers have discovered a possible link between glipizide and increased heart-related risks. Here's what the study found, what it truly means, and why this matters to families where diabetes is part of everyday conversations. Glipizide: Familiar, trusted, But now under scrutiny Glipizide belongs to a group of drugs called sulfonylureas. For decades, these medications have been trusted for lowering blood sugar in people with type 2 diabetes, often when metformin alone isn't enough. What made glipizide popular was its affordability and long-standing availability. But popularity doesn't always mean perfection. The latest study signals a possible red flag. Involving nearly 48,000 individuals, this research found that those taking glipizide had a higher risk of heart attacks, strokes, heart failure hospitalisations, and even cardiovascular-related deaths than those taking a newer class of drugs called DPP-4 inhibitors. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like You Won't Believe the Price of These Dubai Apartments Binghatti Developers FZE Get Offer Undo The numbers that raised eyebrows The research compared glipizide with other sulfonylureas like glimepiride and glyburide, along with DPP-4 inhibitors. Here's what stood out: Over a 5-year period, the risk of major heart events was 9.1% in those taking glipizide, while for those on DPP-4 inhibitors, it was 8.1%. The risk ratio for glipizide users was 1.13, indicating a 13% higher risk of cardiovascular events compared to DPP-4 inhibitor users. The risk was also slightly higher with glimepiride (8.6%) and glyburide (8.4%), but not statistically significant. What makes this important is that most participants were on their second diabetes medication after metformin, a common scenario in diabetes care. And they weren't at extremely high cardiac risk to begin with, just moderate, everyday individuals managing a chronic condition. Not just about the numbers, but about what they mean It's easy to be alarmed by statistics. But what do these numbers truly tell us? Firstly, the study doesn't claim that glipizide causes heart problems directly. What it suggests is a possible association, a pattern that raises concerns, especially in people already facing moderate cardiovascular risk. The heart, after all, is already under pressure in type 2 diabetes. When a drug meant to help with sugar control potentially adds to that risk, even slightly, it becomes a serious discussion for healthcare providers. Why affordability might come at a cost Sulfonylureas like glipizide are often the go-to option in low- and middle-income settings because they're inexpensive. DPP-4 inhibitors, on the other hand, are costlier but have a more favourable cardiovascular safety profile. This raises a deeper, more sensitive question: should treatment decisions depend on cost or safety? The answer isn't straightforward. But studies like this push for better informed decisions, where doctors weigh more than just sugar levels, they also look at heart health, overall risk, and long-term quality of life. What this means for families dealing with diabetes This isn't about pushing panic buttons. Glipizide is still an approved and effective drug. But the study offers important insights for personalised diabetes management. It's a reminder that medications work differently for different people, and what works well for one might not be ideal for another, especially when silent risks like cardiovascular strain are involved. It's also a cue to revisit older medications with a fresh lens, especially when newer, safer options are available. The story here isn't about fear, but about awareness and agency. (Inputs from agencies)
Time of India
4 hours ago
- Time of India
NASA says 20% of workforce to depart space agency
About 20% of the employees at the U.S. National Aeronautics and Space Administration are set to depart the space agency, a NASA spokesperson said on Friday. Around 3,870 individuals are expected to depart, but that number may change in the coming days and weeks, the spokesperson said, adding that the remaining number of employees at the agency would be around 14,000. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Top Public Speaking Course for Children Planet Spark Book Now Undo
Time of India
4 hours ago
- Time of India
'Safety remains a top priority': Nasa says 20% of workforce to depart space agency; here's why
AP file photo Around 20% of Nasa's workforce is expected to leave the agency, a spokesperson of the agency confirmed to news agency Reuters on Friday. Roughly 3,870 employees are projected to depart, although the figure could change in the coming days and weeks After the departures, Nasa's workforce would stand at 14,000 employees. The shake-up comes as the Trump administration moves to cut staff and faces growing concerns over steep budget reductions for the agency. "Safety remains a top priority for our agency as we balance the need to become a more streamlined and more efficient organization and work to ensure we remain fully capable of pursuing a Golden Era of exploration and innovation, including to the Moon and Mars," stated Nasa spokesperson Cheryl Warner as quoted by CBS News. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like No annual fees for life UnionBank Credit Card Apply Now Undo The White House has proposed cutting Nasa's science budget by nearly 50 per cent. 'We are losing some of the brightest minds of our time,' said Democratic leader George Whitesides, a former Nasa chief of staff and the vice-ranking member of the House committee overseeing the agency. 'It will have terrible implications for decades to come,' he was quoted as saying to Politico. Nasa employs around 17,000 people, but about 80 per cent of those expected to leave are senior officials. These are top-level leaders responsible for major engineering projects, such as Mars rover missions. The staff drain would result in depriving the agency of 'highly specialized, irreplaceable knowledge crucial to carrying out Nasa's mission,' said Nasa administrator Sean Duffy. Other major centres like the Johnson Space Center, Nasa headquarters, Langley Research Center, Kennedy Space Center, and Marshall Space Flight Center are set to lose around 400 employees each, according to Politico. These centers handle most of Nasa's human spaceflight operations, aviation research, rocket launches, and engineering work. Without them, the agency is incapable of running the International Space Station, send payloads into orbit, or plan missions to the Moon. The Goddard Space Flight Center under Nasa is set to witness the exiting of nearly 800 of its 3,000 staff. The center is responsible for space probes and major projects, such as infrared space telescopes.
